A Post Marketing Surveillance Study of Cetuximab in Patients With Squamous Cell Carcinoma of Head and Neck (SCCHN)

Clinical trial NCT01080066 · COMPLETED

Trial details

NCT number: NCT01080066
Sponsor: Merck KGaA, Darmstadt, Germany
Status: COMPLETED
Study type: OBSERVATIONAL

Carcinoma, Squamous Cell of Head and Neck

Start date: 2010-09-01
Primary completion: 2013-12-01
Enrollment: 215

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.